from Showa Denko K.K., Kawasaki, Japan. All other compounds were purchased from Sigma Chemical Co., St Louis, MO and Tocris Cookson Inc., Ellisville, MO.
The digitized data were analyzed off-line using the Mini-Analysis Program (Synaptosoft, Leonia, NJ) or pCLAMP9 (Axon Instruments, Union City, CA). Miniature EPSCs were identified and confirmed by analyzing the rise time, decay time, and waveform of each individual spontaneous event.
General data analysis. Values are reported as mean ± SEM. Prior to parametric testing, the assumption of normality was validated using the Kolmogorov-Smirnov test with Lilliefor's correction (SSPS v10, SPSS, Inc., Chicago, IL) . Multiple comparisons among groups were analyzed using ANOVA (two or one way repeated measures with 2 or 1 way replication where appropriate) followed by Student-Newman-Keuls testing.
Single comparisons were analyzed using a 2-tailed Student's t test. A P < 0.05 was considered significant. This article has not been copyedited and formatted. The final version may differ from this version. 
Results

Effect of 3,5-DBr-L-Phe on NMDA receptor function
The NMDA receptor-mediated miniature excitatory postsynaptic currents (mEPSCs) in rat cultured neurons were recorded in Mg 2+ -free extracellular solution in the presence of AMPA/kainate, glycine and GABA receptor blockers and were analyzed as fluctuating background inward current (noise). 3,5-DBr-L-Phe, added to the extracellular solution, increased this current in a concentration-dependent manner ( Figure 1A) . The augmenting effect of 3,5-DBr-L-Phe was detectable at concentrations as low as 10 µM and reached its maximum at concentrations of 1000 µM. The effect of 3,5-DBr-L-Phe at low concentrations (less than 30 µM) appeared as potentiation of the mEPSCs, whereas at higher concentrations 3, 5-DBr-L-Phe activated the steady-state inward current ( Figure 1A ). The concentration of 3,5-DBr-L-Phe required to produce half-maximal effect (EC 50 ) was 331.6±78.6 µM. The concentration-response relationships for 3,5-DBr-L-Phe to activate total steady-state and fluctuating background inward currents are shown in Figure 1B and 1C, respectively. Compared to NMDA-activated current, 3,5-DBr-L-Phe-activated current had a similar onset and reverted to base line on washout of 3,5-DBr-L-Phe (see Figure 1A ). The NMDA receptor antagonist, AP-5, and the NMDA receptor channel blocker, MK-801 (not shown), completely blocked current activated by 3,5-DBr-L-Phe ( Figure 1D ).
In order to elucidate whether 3,5-DBr-L-Phe interacts with the glutamate-or glycine-binding sites on NMDA receptors we measured its effects in the presence of different concentrations of glycine, glutamate and NMDA added to the extracellular solution. A 100-fold increase in concentration of glycine from 0.1 µM to 10 µM did not This article has not been copyedited and formatted. The final version may differ from this version. prevent the augmenting effect of 3,5-DBr-L-Phe on NMDA receptor mediated current ( Figure 2A ). 3,5-DBr-L-Phe (100 µM) activated NMDA receptor-mediated current of 67.4 ±16.4 and 144.4±32.7 pA in the presence of 0.1 and 10 µM of glycine, respectively.
In order to obtain further evidence whether or not 3,5-DBr-L-Phe interacts with the glycine-binding site of NMDA receptors, the dose-response curves for glycine to modulate NMDA current were generated in the absence and presence of 3,5-DBr-L-Phe.
These dose-response curves overlapped ( Fig 2B) indicating that augmentation of NMDA receptor current by 3,5-DBr-L-Phe cannot be explained by its interaction with the glycine-binding site of NMDA receptors. The effect of 3,5-DBr-L-Phe on NMDA receptor function, however, did depend on the concentration of glutamate or NMDA. At low concentrations of glutamate and NMDA, total NMDA receptor-mediated current activated by both glutamate or NMDA and 3,5-DBr-L-Phe was bigger than the current recorded in response to application of glutamate or NMDA only. In contrast, combined current, activated by both 3,5-DBr-L-Phe and higher concentration of glutamate or NMDA, was either smaller or similar to the current recorded in the presence of glutamate or NMDA only (Figure 2C, D) . Comparison of the concentration-response relationships for 3,5-DBr-L-Phe and NMDA to activate NMDA receptor-mediated currents showed that efficacy for 3,5-DBr-L-Phe was 30.5±4.7 % compared with NMDA ( Figure 2E ,F). Similar efficacy for 3,5-DBr-L-Phe was observed when instead of NMDA glutamate was used as agonist (data not shown). These results demonstrate that 3,5-DBr-L-Phe acts as a partial agonist of the glutamate-binding site of NMDA receptors.
Effect of 3,5-DBr-L-Phe on glutamate release and AMPA/kainate receptor function
This article has not been copyedited and formatted. The final version may differ from this version. In order to assess whether 3,5-DBr-L-Phe may also depress activity of postsynaptic AMPA/kainate receptors, we investigated the effect of 3,5-DBr-L-Phe on current activated by AMPA. AMPA (3 µM) activated a rapidly rising inward current (i.e., I AMPA ) that was depressed by 3,5-DBr-L-Phe ( Figure 4C ). The effect of 3,5-DBr-L-Phe on I AMPA was concentration-dependent and reversible upon washout of the drug. The concentration-response relationships for 3,5-DBr-L-Phe to depress I AMPA obtained at two different concentrations of AMPA are shown in Figure 4D . The increase in the This article has not been copyedited and formatted. The final version may differ from this version. concentration of AMPA from 3 µ to 10 µM markedly shifted the concentration-response relationship for 3,5-DBr-L-Phe to depress I AMPA rightward ( Figure 4D ). The IC 50 values of 3,5-DBr-L-Phe in the presence of 3 µM and 10 µM AMPA were 294.4±8.9 µM and 1140.1±54.6 µM, respectively. These results indicate that 3,5-DBr-L-Phe, most likely, acts as a competitive inhibitor of the glutamate-binding site on the AMPA receptors.
Effect of 3,5-DBr-L-Phe on GABA-ergic transmission and elicited action potentials
GABA receptor-mediated miniature inhibitory postsynaptic currents (mIPSCs) were recorded in the presence of MK-801 (5 µM 
Discussion
The results of the current study clearly demonstrate that 3,5-DBr-L-Phe produces a unique combination of actions on excitatory glutamatergic synaptic transmission in rat cerebrocortical cultured neurons. Specifically, 3,5-DBr-L-Phe activates NMDA receptormediated current, depresses activity of non-NMDA (AMPA/kainate) subtype of glutamate receptors, and diminishes pre-synaptic glutamate release. Such differential modulation of glutamatergic synaptic transmission may be beneficial in brain disorders characterized by alterations in the glutamate system.
Mechanism of action
Current activated by 3,5-DBr-L-Phe was blocked by the specific NMDA receptor antagonists, AP-5 and MK-801. These and other experimental evidence indicate that 3,5-DBr-L-Phe acts as agonist of NMDA receptors. NMDA receptors require two co-agonists, glutamate and glycine for their activation. The binding sites for glycine and glutamate are located on subunits 1 and 2, respectively (Laube et al., 1997) . Earlier, we have demonstrated that L-Phe depressed NMDA receptor function by competing for the glycine-binding site of NMDA receptors and depressed non-NMDA receptor activity by competing for the glutamate-binding site of these receptors (Glushakov et al., 2002; Glushakov et al., 2003) . Similar to L-Phe, 3,5-DBr-L-Phe is a competitive antagonist of AMPA/kainate receptors also. Surprisingly, halogenation of the L-Phe molecule not only reversed its effect (activation vs. depression), but also changed the site of its interaction with the NMDA receptors (glutamate-binding site vs. glycine-binding site). Thus, the activating effect of 3,5-DBr-L-Phe on NMDA receptor function did not depend on This article has not been copyedited and formatted. The final version may differ from this version. 
Potential application of 3,5-DBr-L-Phe
Given the fact that decreased function of NMDA receptors and accompanying increased neurotransmitter release with overactivation of AMPA/kainate receptors are important contributors to the pathophysiology of schizophrenia (Hirsh and Weinberger, 2003; Konradia and Heckers, 2003; Jentsch and Roth, 1999; Moghaddam et al., 1997; Meador-Woodruff and Healy, 2000; Greene, 2001) 
